INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain
Pain was one of the first sensations Brandy, 44, remembers. Born with spina bifida occulta, a defect that kept part of her spine from fully…
Nov 3, 2025Pain was one of the first sensations Brandy, 44, remembers. Born with spina bifida occulta, a defect that kept part of her spine from fully…
Nov 3, 2025Two-thirds of Americans say they would be willing to pay more for medications if they were tested by an independent third party to ensure their…
Sep 15, 2025On Sept 17, 2025, the Senate Committee on Aging held a bipartisan hearing to discuss issues with drug manufacturing that put Americans — especially older Americans who…
Sep 23, 2025Since MedShadow began publishing our investigative series on quality issues with generic ADHD medications, thousands of people have commented on our TikTok account about their own experiences, and many…
Sep 29, 2025Over the past few months, MedShadow has examined inconsistencies in the quality of ADHD medications. Our reporting uncovered evidence that certain generic medications dissolve at different rates than…
Sep 3, 2025For two years, Molly’s ADHD medication, a generic form of Vyvanse called lisdexamfetamine dimesylate, had come in the form of a teal pill that was…
Jul 28, 2025Eight years ago, Lisa Salberg, now 56, received a heart transplant at Newark Beth Israel Medical Center in New Jersey after living with hypertrophic cardiomyopathy (a heart…
Jun 19, 2025The first time Marilynn Monroe took Adderall (a combination of amphetamine and dextroamphetamine) for her ADHD, she says she cried tears of joy. She was…
May 30, 2025In early September 2024, an Associated Press (AP) investigation revealed that the FDA has struggled to keep up with lab inspections, especially those based overseas. The agency faces…
Nov 13, 2024Hundreds of FDA-approved drugs on the market may have been approved based on fraudulent trials. This is according to a notice from the U.S. Food and Drug…
Oct 28, 2024The FDA revealed on June 18, 2024, that an unnamed number of drugs on the market right now were approved based on potentially fraudulent testing and data.1 This means there’s…
Jul 23, 2024Experts unpack what patients should know about generic drugs, quality concerns, and FDA oversight.
Help fund our fight for improved medication safety and transparency by supporting our independent journalism.
Give NowIndependent, science-based journalism delivered directly to your inbox.
Want to hear expert insights about medication safety and other care options? Watch all our past webinars and sign up for upcoming ones.
WATCH Now